跳至主要内容
临床试验/NL-OMON56360
NL-OMON56360尚未招募不适用

Hybrid Epicardial and Endocardial Sinus-Node SpAring AbLation Therapy for Inappropriate Sinus Tachycardia - HEAL-IST IDE-study

AtriCure, Inc0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
AtriCure, Inc
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age >= 18 years and <= 75 years at time of enrollment consent
  • 2. Subject has a diagnosis of IST:
  • a. Documentation of mean heart rate > 90bpm with 7-day monitor within 90 days
  • of the Index Procedure and;
  • b. Documentation of a resting heart rate of >100bpm and;
  • c. Documentation of presence of IST for at least 6-months
  • d. Documentation of absence of other tachycardia
  • e. Documentation of absence of secondary causes such as hormonal issues or
  • systemic illness that might contribute to increased heart rate
  • 3. Documentation of refractoriness (intolerance or failure) of a drug (e.g.,
  • rate control drugs such as beta-blockers/calcium channel blockers, ivabradine),
  • and/or AADs
  • 4. Subject is willing and able to provide written informed consent

排除标准

  • 1. Subjects on whom cardiac surgery or single lung ventilation cannot be
  • 2. Subjects with indication for or existing ICDs/Pacemakers
  • 3. Presence of channelopathies
  • 4. Previous cardio-thoracic surgery
  • 5. Left Ventricular Ejection Fraction (LVEF) < 50%
  • 6. Body Mass Index (BMI) >= 35
  • 7. Presence of supraventricular or ventricular tachycardia
  • 8. Presence of Postural Orthostatic Sinus Tachycardia (POTS)
  • 9. Presence of congenital heart disease
  • 10. History suggestive of secondary cause of tachycardia such as
  • pheochromocytoma, anemia, thyrotoxicosis, chronic fever of unknown origin,
  • COPD, long-term bronchodilators use,
  • severe asthma or carcinoid syndrome
  • 11. Subjects who have had a previous catheter ablation in the right atrium for
  • IST or other disorders;
  • Allowed catheter ablation in the right atrium:
  • a) One previous catheter ablation > 90 days prior to the Index
  • Procedure for AVRT or CTI
  • b) One previous catheter ablation > 180 days prior to the Index
  • Procedure for AVNRT
  • 12. Life expectancy < 24 months
  • 13. Pregnant or planning to become pregnant during trial
  • 14. Subjects with substance abuse
  • 15. Subjects with previous weight loss surgery
  • 16. Subject is unwilling and/or unable to return for scheduled follow-up visits
  • 17. Current participation in another clinical investigation of a medical device
  • or a drug, or recent participation in such a trial that may interfere with
  • trial results
  • 18. Not competent to legally represent him or herself (e.g., requires a
  • guardian or caretaker as a legal representative) and;
  • 19. Presence of other anatomic or comorbid conditions, or other medical,
  • social, or psychological conditions that, in the investigator*s opinion, could
  • limit the subject*s ability to
  • participate in the clinical investigation or to comply with follow-up
  • requirements, or impact the scientific soundness of the clinical investigation

研究者

发起方
AtriCure, Inc

相似试验